<?xml version="1.0"?>
<rss version="2.0" xmlns:blogChannel="http://backend.userland.com/blogChannelModule">
	<channel>
		<title>Medscape Ophthalmology Headlines</title>
		<link>http://www.medscape.com/ophthalmology?src=rss</link>
		<description>Latest medical news, articles, and features from Medscape Ophthalmology</description>
		<image>
			<url>http://images.medscape.com/pi/global/logos/mscp/logo-medscape110x30.gif</url>
			<title>Medscape Ophthalmology Headlines</title>
			<link>http://www.medscape.com/ophthalmology?src=rss</link>
		</image>
		<language>en-us</language>
		<copyright>Copyright 2008, Medscape</copyright>
		<pubDate>Fri, 29 Aug 2008 14:05:26 EDT</pubDate>
		<managingEditor>ophtheditor@medscape.net</managingEditor>
		<webMaster>medscapecustomersupport@webmd.net (Medscape Customer Support)</webMaster>

		<item>
			<title>Electronic Personal Health Records: Should Doctors Worry?</title>
			<link>http://www.medscape.com/viewarticle/579181?src=rss</link>
			<description>Matthew K. Wynia, MD, MPH, FACP, Director, The Institute for Ethics, American Medical Association, Chicago, Illinois, describes many ethical twists in electronic health records. 
  &lt;br /&gt; &lt;i&gt;The Medscape Journal of Medicine&lt;/i&gt;</description>
			<category>Internal Medicine</category>
					<pubDate>Fri, 29 Aug 2008 09:18:50 EDT</pubDate>
		</item>
		<item>
			<title>Supplementation and AMD: An Update of AREDS and AREDS2</title>
			<link>http://www.medscape.com/viewarticle/578905?src=rss</link>
			<description>Dr. Emily Chew reviews the latest findings concerning diet and the risk of AMD from AREDS as well as the ongoing AREDS2. 
  &lt;br /&gt; &lt;i&gt;Medscape Ophthalmology&lt;/i&gt;</description>
			<category>Ophthalmology</category>
					<pubDate>Wed, 27 Aug 2008 14:17:19 EDT</pubDate>
		</item>
		<item>
			<title>UK&apos;s NICE Recommends Novartis Eye Drug Lucentis</title>
			<link>http://www.medscape.com/viewarticle/579716?src=rss</link>
			<description>Britain&apos;s healthcare cost-effectiveness watchdog NICE has recommended Novartis AG&apos;s pricey eye drug Lucentis, under a special scheme that will cap the cost of treatment to the state health service.  &lt;br /&gt; &lt;i&gt;Reuters Health Information&lt;/i&gt;</description>
			<category>Business of Medicine</category>
					<pubDate>Wed, 27 Aug 2008 22:46:10 EDT</pubDate>
		</item>
		<item>
			<title>Improvements With Different Amblyopia Treatments Are Similar and Sustained</title>
			<link>http://www.medscape.com/viewarticle/579624?src=rss</link>
			<description>Atropine and patching are comparable for the treatment of moderate amblyopia in young children, a study indicates, and the improvement of the amblyopic eye is maintained at age 10 years.  &lt;br /&gt; &lt;i&gt;Reuters Health Information&lt;/i&gt;</description>
			<category>Ophthalmology</category>
					<pubDate>Thu, 28 Aug 2008 22:54:45 EDT</pubDate>
		</item>
		<item>
			<title>Safeguarding Muscle During Weight Reduction</title>
			<link>http://www.medscape.com/viewarticle/578880?src=rss</link>
			<description>Ingrid Kohlstadt, MD, MPH, FACN, Associate, The Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD, explains the muscle part of weight gain and loss. 
  &lt;br /&gt; &lt;i&gt;The Medscape Journal of Medicine&lt;/i&gt;</description>
			<category>Internal Medicine</category>
					<pubDate>Mon, 25 Aug 2008 08:44:50 EDT</pubDate>
		</item>
		<item>
			<title>A Principled Partnership Between Academic Medicine and Industry</title>
			<link>http://www.medscape.com/viewarticle/578877?src=rss</link>
			<description>Darrell G. Kirch, MD, President and CEO, Association of American Medical Colleges, Washington, DC, tells us how medicine and industry can and cannot collaborate. 
  &lt;br /&gt; &lt;i&gt;The Medscape Journal of Medicine&lt;/i&gt;</description>
			<category>Internal Medicine</category>
					<pubDate>Fri, 22 Aug 2008 08:56:16 EDT</pubDate>
		</item>
		<item>
			<title>Zoledronic Acid Prevents Bone Loss During Breast Cancer Treatment</title>
			<link>http://www.medscape.com/viewarticle/579466?src=rss</link>
			<description>Zoledronic acid can prevent bone loss in premenopausal breast cancer patients who are receiving endocrine therapy and also improves bone-mineral density after treatment.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Hematology-Oncology</category>
					<pubDate>Fri, 22 Aug 2008 11:14:21 EDT</pubDate>
		</item>

</channel>
</rss>